Relmada Historical Cash Flow

RLMD Stock  USD 0.63  2.14  77.26%   
Analysis of Relmada Therapeutics cash flow over time is an excellent tool to project Relmada Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as End Period Cash Flow of 3.9 M or Sale Purchase Of Stock of 35.1 M as it is a great indicator of Relmada Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Relmada Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Relmada Therapeutics is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Relmada Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.

About Relmada Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Relmada balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Relmada's non-liquid assets can be easily converted into cash.

Relmada Therapeutics Cash Flow Chart

At present, Relmada Therapeutics' Change In Working Capital is projected to increase significantly based on the last few years of reporting. The current year's Total Cashflows From Investing Activities is expected to grow to about 18.6 M, whereas Free Cash Flow is projected to grow to (49.1 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from Relmada Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Relmada Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Relmada Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.At present, Relmada Therapeutics' Change In Working Capital is projected to increase significantly based on the last few years of reporting. The current year's Total Cashflows From Investing Activities is expected to grow to about 18.6 M, whereas Free Cash Flow is projected to grow to (49.1 M).

Relmada Therapeutics cash flow statement Correlations

-0.29-0.40.450.210.02-0.45-0.180.290.0-0.340.450.21-0.05-0.460.450.830.270.540.56-0.3-0.37
-0.290.03-0.59-0.74-0.170.080.580.04-0.140.08-0.05-0.34-0.030.240.16-0.60.11-0.04-0.310.030.58
-0.40.03-0.34-0.410.140.97-0.46-0.360.250.75-0.73-0.560.210.41-0.21-0.23-0.64-0.89-0.190.72-0.58
0.45-0.59-0.340.60.07-0.31-0.140.390.06-0.480.460.48-0.07-0.590.20.480.020.360.07-0.43-0.19
0.21-0.74-0.410.60.2-0.370.120.10.09-0.360.20.38-0.15-0.5-0.210.26-0.140.220.15-0.23-0.05
0.02-0.170.140.070.20.260.0-0.130.560.19-0.24-0.33-0.04-0.550.05-0.1-0.35-0.230.060.26-0.08
-0.450.080.97-0.31-0.370.26-0.33-0.370.350.79-0.8-0.680.230.32-0.29-0.37-0.74-0.95-0.270.77-0.47
-0.180.58-0.46-0.140.120.0-0.330.18-0.1-0.310.17-0.04-0.23-0.24-0.02-0.57-0.020.22-0.27-0.230.8
0.290.04-0.360.390.1-0.13-0.370.18-0.14-0.770.740.3-0.2-0.470.210.130.080.34-0.35-0.740.14
0.0-0.140.250.060.090.560.35-0.1-0.140.32-0.34-0.370.78-0.430.21-0.16-0.49-0.340.050.56-0.11
-0.340.080.75-0.48-0.360.190.79-0.31-0.770.32-0.96-0.70.310.45-0.37-0.3-0.49-0.78-0.030.92-0.34
0.45-0.05-0.730.460.2-0.24-0.80.170.74-0.34-0.960.76-0.27-0.410.520.430.630.850.1-0.940.26
0.21-0.34-0.560.480.38-0.33-0.68-0.040.3-0.37-0.70.76-0.21-0.230.460.460.60.740.17-0.730.1
-0.05-0.030.21-0.07-0.15-0.040.23-0.23-0.20.780.31-0.27-0.210.00.23-0.1-0.2-0.210.120.52-0.08
-0.460.240.41-0.59-0.5-0.550.32-0.24-0.47-0.430.45-0.41-0.230.0-0.4-0.180.15-0.320.070.34-0.1
0.450.16-0.210.2-0.210.05-0.29-0.020.210.21-0.370.520.460.23-0.40.380.40.530.39-0.28-0.05
0.83-0.6-0.230.480.26-0.1-0.37-0.570.13-0.16-0.30.430.46-0.1-0.180.380.380.490.66-0.31-0.63
0.270.11-0.640.02-0.14-0.35-0.74-0.020.08-0.49-0.490.630.6-0.20.150.40.380.830.43-0.590.29
0.54-0.04-0.890.360.22-0.23-0.950.220.34-0.34-0.780.850.74-0.21-0.320.530.490.830.4-0.770.34
0.56-0.31-0.190.070.150.06-0.27-0.27-0.350.05-0.030.10.170.120.070.390.660.430.40.11-0.38
-0.30.030.72-0.43-0.230.260.77-0.23-0.740.560.92-0.94-0.730.520.34-0.28-0.31-0.59-0.770.11-0.33
-0.370.58-0.58-0.19-0.05-0.08-0.470.80.14-0.11-0.340.260.1-0.08-0.1-0.05-0.630.290.34-0.38-0.33
Click cells to compare fundamentals

Relmada Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Relmada Therapeutics is a strong investment it is important to analyze Relmada Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Relmada Therapeutics' future performance. For an informed investment choice regarding Relmada Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Relmada Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Relmada Therapeutics. If investors know Relmada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Relmada Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.86)
Return On Assets
(0.59)
Return On Equity
(1.00)
The market value of Relmada Therapeutics is measured differently than its book value, which is the value of Relmada that is recorded on the company's balance sheet. Investors also form their own opinion of Relmada Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Relmada Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Relmada Therapeutics' market value can be influenced by many factors that don't directly affect Relmada Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Relmada Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Relmada Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Relmada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.